These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33294739)

  • 1. β-Arrestin-Biased AT
    Kashihara T; Kawagishi H; Nakada T; Numaga-Tomita T; Kadota S; Wolf EE; Du CK; Shiba Y; Morimoto S; Yamada M
    JACC Basic Transl Sci; 2020 Nov; 5(11):1057-1069. PubMed ID: 33294739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A novel way of modification of AT
    Kawagishi H; Yamada M
    Nihon Yakurigaku Zasshi; 2021; 156(6):351-354. PubMed ID: 34719568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II activates Ca
    Kashihara T; Nakada T; Kojima K; Takeshita T; Yamada M
    J Physiol; 2017 Jul; 595(13):4207-4225. PubMed ID: 28295363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased Agonism of the Angiotensin II Type I Receptor.
    Ikeda Y; Kumagai H; Motozawa Y; Suzuki J; Komuro I
    Int Heart J; 2015; 56(5):485-8. PubMed ID: 26180022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Arrestin-Biased Agonist Targeting the Brain AT
    Zanaty M; Seara FAC; Nakagawa P; Deng G; Mathieu NM; Balapattabi K; Karnik SS; Grobe JL; Sigmund CD
    Hypertension; 2021 Feb; 77(2):420-431. PubMed ID: 33249862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Mechanisms of β-Arrestin-Biased Agonist and Blocker of AT1R in Preventing Aortic Aneurysm and Associated Mortality.
    Jara ZP; Harford TJ; Singh KD; Desnoyer R; Kumar A; Srinivasan D; Karnik SS
    Hypertension; 2023 Feb; 80(2):385-402. PubMed ID: 36440576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of AT
    Port JD
    JACC Basic Transl Sci; 2020 Nov; 5(11):1070-1072. PubMed ID: 33296444
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative evaluation of biased agonists Sarcosine
    Noto NM; Restrepo YM; Pang HW; Stoyell-Conti F; West CA; Speth RC
    Pharmacol Res Perspect; 2023 Feb; 11(1):e01053. PubMed ID: 36639940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
    Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
    Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analyses of downstream signal transduction targets modulated after activation of the AT1 receptor by two β-arrestin-biased agonists.
    Santos GA; Duarte DA; Parreiras-E-Silva LT; Teixeira FR; Silva-Rocha R; Oliveira EB; Bouvier M; Costa-Neto CM
    Front Pharmacol; 2015; 6():131. PubMed ID: 26191004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT
    Teixeira LB; Parreiras-E-Silva LT; Bruder-Nascimento T; Duarte DA; Simões SC; Costa RM; Rodríguez DY; Ferreira PAB; Silva CAA; Abrao EP; Oliveira EB; Bouvier M; Tostes RC; Costa-Neto CM
    Sci Rep; 2017 Sep; 7(1):11903. PubMed ID: 28928410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure).
    Felker GM; Butler J; Collins SP; Cotter G; Davison BA; Ezekowitz JA; Filippatos G; Levy PD; Metra M; Ponikowski P; Soergel DG; Teerlink JR; Violin JD; Voors AA; Pang PS
    JACC Heart Fail; 2015 Mar; 3(3):193-201. PubMed ID: 25650371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose angiotensin AT
    Esmaeeli A; Ebrahimi F; Tanha K; Assadi M; Seyedabadi M
    Pharmacol Rep; 2020 Dec; 72(6):1676-1684. PubMed ID: 33090352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model.
    Tarigopula M; Davis RT; Mungai PT; Ryba DM; Wieczorek DF; Cowan CL; Violin JD; Wolska BM; Solaro RJ
    Cardiovasc Res; 2015 Jul; 107(2):226-34. PubMed ID: 26045475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
    Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
    J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
    Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship study of angiotensin II analogs in terms of β-arrestin-dependent signaling to aldosterone production.
    Valero TR; Sturchler E; Jafferjee M; Rengo G; Magafa V; Cordopatis P; McDonald P; Koch WJ; Lymperopoulos A
    Pharmacol Res Perspect; 2016 Apr; 4(2):e00226. PubMed ID: 27069636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy.
    Lymperopoulos A; Aukszi B
    World J Cardiol; 2017 Mar; 9(3):200-206. PubMed ID: 28400916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways.
    Pang HW; Linares A; Couling L; Santollo J; Ancheta L; Daniels D; Speth RC
    Endocrine; 2019 Nov; 66(2):349-359. PubMed ID: 31020463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.
    Gagnon L; Cao Y; Cho A; Sedki D; Huber T; Sakmar TP; Laporte SA
    J Biol Chem; 2019 Nov; 294(46):17409-17420. PubMed ID: 31530642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.